» Articles » PMID: 27104955

Air Pollution-induced Placental Epigenetic Alterations in Early Life: a Candidate MiRNA Approach

Overview
Journal Epigenetics
Specialty Genetics
Date 2016 Apr 23
PMID 27104955
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Particulate matter (PM) exposure during in utero life may entail adverse health outcomes in later-life. Air pollution's adverse effects are known to alter gene expression profiles, which can be regulated by microRNAs (miRNAs). We investigate the potential influence of air pollution exposure in prenatal life on placental miRNA expression. Within the framework of the ENVIRONAGE birth cohort, we measured the expression of six candidate miRNAs in placental tissue from 210 mother-newborn pairs by qRT-PCR. Trimester-specific PM exposure levels were estimated for each mother's home address using a spatiotemporal model. Multiple regression models were used to study miRNA expression and in utero exposure to PM over various time windows during pregnancy. The placental expression of miR-21 (-33.7%, 95% CI: -53.2 to -6.2, P = 0.022), miR-146a (-30.9%, 95% CI: -48.0 to -8.1, P = 0.012) and miR-222 (-25.4%, 95% CI: -43.0 to -2.4, P = 0.034) was inversely associated with PM exposure during the 2nd trimester of pregnancy, while placental expression of miR-20a and miR-21 was positively associated with 1st trimester exposure. Tumor suppressor phosphatase and tensin homolog (PTEN) was identified as a common target of the miRNAs significantly associated with PM exposure. Placental PTEN expression was strongly and positively associated (+59.6% per 5 µg/m³ increment, 95% CI: 26.9 to 100.7, P < 0.0001) with 3rd trimester PM exposure. Further research is required to establish the role these early miRNA and mRNA expression changes might play in PM-induced health effects. We provide molecular evidence showing that in utero PM exposure affects miRNAs expression as well as its downstream target PTEN.

Citing Articles

C3AR1 as a target for preeclampsia: from bioinformatics and network pharmacology to experimental validation.

Hu Y, Li S, Hong Y, Peng D BMC Pregnancy Childbirth. 2025; 25(1):94.

PMID: 39885406 PMC: 11780793. DOI: 10.1186/s12884-025-07221-y.


Copy Number Variation in Asthma: An Integrative Review.

Garcia F, de Sousa V, Silva-Dos-Santos P, Fernandes I, Sarquis Serpa F, Paula F Clin Rev Allergy Immunol. 2025; 68(1):4.

PMID: 39755867 DOI: 10.1007/s12016-024-09015-0.


MicroRNAs as promising drug delivery target to ameliorate chronic obstructive pulmonary disease using nano-carriers: a comprehensive review.

Khanna V, Singh K Mol Cell Biochem. 2024; 480(3):1431-1448.

PMID: 39254870 DOI: 10.1007/s11010-024-05110-0.


Prenatal Exposure to Air Pollutants Associated with Allergic Diseases in Children: Which Pollutant, When Exposure, and What Disease? A Systematic Review and Meta-analysis.

Ai S, Liu L, Xue Y, Cheng X, Li M, Deng Q Clin Rev Allergy Immunol. 2024; 66(2):149-163.

PMID: 38639856 DOI: 10.1007/s12016-024-08987-3.


Epigenetic mechanisms of particulate matter exposure: air pollution and hazards on human health.

Gavito-Covarrubias D, Ramirez-Diaz I, Guzman-Linares J, Limon I, Manuel-Sanchez D, Molina-Herrera A Front Genet. 2024; 14:1306600.

PMID: 38299096 PMC: 10829887. DOI: 10.3389/fgene.2023.1306600.


References
1.
Jansson T, Powell T . Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond). 2007; 113(1):1-13. DOI: 10.1042/CS20060339. View

2.
Rappazzo K, Daniels J, Messer L, Poole C, Lobdell D . Exposure to fine particulate matter during pregnancy and risk of preterm birth among women in New Jersey, Ohio, and Pennsylvania, 2000-2005. Environ Health Perspect. 2014; 122(9):992-7. PMC: 4154214. DOI: 10.1289/ehp.1307456. View

3.
Kuhn D, Martin M, Feldman D, Terry Jr A, Nuovo G, Elton T . Experimental validation of miRNA targets. Methods. 2007; 44(1):47-54. PMC: 2237914. DOI: 10.1016/j.ymeth.2007.09.005. View

4.
Etheridge A, Lee I, Hood L, Galas D, Wang K . Extracellular microRNA: a new source of biomarkers. Mutat Res. 2011; 717(1-2):85-90. PMC: 3199035. DOI: 10.1016/j.mrfmmm.2011.03.004. View

5.
Urbich C, Kuehbacher A, Dimmeler S . Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res. 2008; 79(4):581-8. DOI: 10.1093/cvr/cvn156. View